Medical Use of Cannabis and Cannabinoids
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 8880
Special Issue Editor
Interests: clinical pharmacology; herbal medicine; nutraceuticals; cannabis; cannabinoids; pain
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
After a long history of Cannabis limited to the description of its use as a substance of abuse, in recent decades this plant and its compounds called cannabinoids have received different attention from the scientific community. In particular, cannabis and cannabinoids are raised up on the scientific scene for their usefulness in the medical field. This new interest has produced and continues to deliver a significant number of results that have been translated into clinical practice. Research on cannabis and cannabinoids is now a useful support inside the medical community in the treatment of chronic pain and, more recently, in the treatment of severe forms of childhood epilepsy (cannabidiol). Beyond the more known delta-9-tetra-hydrocannabinol and cannabidiol, the results obtained with research on other molecules present in the plant, such as cannabigerol and tetrahydrocannabiverine, are encouraging and indicate that Cannabis can still be a source of interesting scientific discoveries that can be translated into useful applications in the field of medicine.
This Special Issue welcomes the submission of unpublished manuscripts (original research papers or review articles) on all aspects of the medical use of cannabis and cannabinoids involved.
Prof. Dr. Gioacchino Calapai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cannabis sativa
- Cannabis
- Cannabinoids
- CB1
- CB2
- Medical use
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
